UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended April 5, 2015
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No. 001-06462
TERADYNE, INC.
(Exact name of registrant as specified in its charter)
Massachusetts | 04-2272148 | |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
600 Riverpark Drive, North Reading, Massachusetts |
01864 | |
(Address of Principal Executive Offices) | (Zip Code) |
978-370-2700
(Registrants Telephone Number, Including Area Code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files) Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act (check one):
Large accelerated filer | x | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
The number of shares outstanding of the registrants only class of Common Stock as of May 1, 2015 was 214,540,853 shares.
TERADYNE, INC.
Page No. | ||||||
PART I. FINANCIAL INFORMATION | ||||||
Item 1. | ||||||
Condensed Consolidated Balance Sheets as of April 5, 2015 and December 31, 2014 |
1 | |||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
22 | ||||
Item 3. | 28 | |||||
Item 4. | 28 | |||||
PART II. OTHER INFORMATION | ||||||
Item 1. | 29 | |||||
Item 1A. | 29 | |||||
Item 2. | 29 | |||||
Item 4. | 30 | |||||
Item 6. | 31 |
Item 1: | Financial Statements |
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
April 5, 2015 |
December 31, 2014 |
|||||||
(in thousands, except per share information) |
||||||||
ASSETS | ||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 218,945 | $ | 294,256 | ||||
Marketable securities |
649,219 | 533,787 | ||||||
Accounts receivable, less allowance for doubtful accounts of $2,430 and $2,491 at April 5, 2015 and December 31, 2014, respectively |
175,783 | 151,034 | ||||||
Inventories, net: |
||||||||
Parts |
72,134 | 70,821 | ||||||
Assemblies in process |
15,927 | 10,347 | ||||||
Finished goods |
32,990 | 23,961 | ||||||
|
|
|
|
|||||
121,051 | 105,129 | |||||||
Deferred tax assets |
56,715 | 57,239 | ||||||
Prepayments |
92,484 | 95,819 | ||||||
Other current assets |
6,959 | 6,582 | ||||||
|
|
|
|
|||||
Total current assets |
1,321,156 | 1,243,846 | ||||||
|
|
|
|
|||||
Property, plant and equipment, net |
308,264 | 329,038 | ||||||
Marketable securities |
402,722 | 470,789 | ||||||
Deferred tax assets |
6,683 | 7,494 | ||||||
Other assets |
10,280 | 10,419 | ||||||
Retirement plans assets |
12,847 | 12,896 | ||||||
Intangible assets, net |
176,792 | 190,600 | ||||||
Goodwill |
273,438 | 273,438 | ||||||
|
|
|
|
|||||
Total assets |
$ | 2,512,182 | $ | 2,538,520 | ||||
|
|
|
|
|||||
LIABILITIES | ||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 59,831 | $ | 47,763 | ||||
Accrued employees compensation and withholdings |
65,396 | 100,994 | ||||||
Deferred revenue and customer advances |
74,252 | 71,603 | ||||||
Other accrued liabilities |
68,943 | 51,997 | ||||||
Accrued income taxes |
24,711 | 20,049 | ||||||
|
|
|
|
|||||
Total current liabilities |
293,133 | 292,406 | ||||||
|
|
|
|
|||||
Long-term deferred revenue and customer advances |
18,318 | 19,929 | ||||||
Retirement plans liabilities |
106,224 | 108,460 | ||||||
Deferred tax liabilities |
20,149 | 23,315 | ||||||
Long-term other accrued liabilities |
17,136 | 15,430 | ||||||
|
|
|
|
|||||
Total liabilities |
454,960 | 459,540 | ||||||
|
|
|
|
|||||
Commitments and contingencies (See Note O) |
||||||||
SHAREHOLDERS EQUITY | ||||||||
Common stock, $0.125 par value, 1,000,000 shares authorized, 215,902 shares and 216,613 shares issued and outstanding at April 5, 2015 and December 31, 2014, respectively |
26,988 | 27,077 | ||||||
Additional paid-in capital |
1,444,579 | 1,437,135 | ||||||
Accumulated other comprehensive income |
6,084 | 4,689 | ||||||
Retained earnings |
579,571 | 610,079 | ||||||
|
|
|
|
|||||
Total shareholders equity |
2,057,222 | 2,078,980 | ||||||
|
|
|
|
|||||
Total liabilities and shareholders equity |
$ | 2,512,182 | $ | 2,538,520 | ||||
|
|
|
|
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradynes
Annual Report on Form 10-K for the year ended December 31, 2014, are an integral part of the condensed
consolidated financial statements.
1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands, except per share amount) |
||||||||
Revenues: |
||||||||
Products |
$ | 272,325 | $ | 255,386 | ||||
Services |
70,076 | 65,624 | ||||||
|
|
|
|
|||||
Total revenues |
342,401 | 321,010 | ||||||
Cost of revenues: |
||||||||
Cost of products |
118,996 | 124,448 | ||||||
Cost of services |
30,982 | 29,515 | ||||||
|
|
|
|
|||||
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) |
149,978 | 153,963 | ||||||
|
|
|
|
|||||
Gross profit |
192,423 | 167,047 | ||||||
Operating expenses: |
||||||||
Engineering and development |
71,450 | 67,085 | ||||||
Selling and administrative |
72,041 | 78,003 | ||||||
Acquired intangible assets amortization |
13,808 | 18,271 | ||||||
|
|
|
|
|||||
Total operating expenses |
157,299 | 163,359 | ||||||
|
|
|
|
|||||
Income from operations |
35,124 | 3,688 | ||||||
Non-operating (income) expenses: |
||||||||
Interest income |
(1,816 | ) | (1,036 | ) | ||||
Interest expense |
162 | 6,417 | ||||||
Other (income) expense, net |
(5,660 | ) | 180 | |||||
|
|
|
|
|||||
Income (loss) before income taxes |
42,438 | (1,873 | ) | |||||
Income tax provision (benefit) |
9,651 | (2,802 | ) | |||||
|
|
|
|
|||||
Net income |
$ | 32,787 | $ | 929 | ||||
|
|
|
|
|||||
Net income per common share: |
||||||||
Basic |
$ | 0.15 | $ | 0.00 | ||||
|
|
|
|
|||||
Diluted |
$ | 0.15 | $ | 0.00 | ||||
|
|
|
|
|||||
Weighted average common sharesbasic |
217,187 | 193,311 | ||||||
|
|
|
|
|||||
Weighted average common sharesdiluted |
218,812 | 236,484 | ||||||
|
|
|
|
|||||
Cash dividend declared per common share |
$ | 0.06 | $ | 0.06 | ||||
|
|
|
|
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradynes
Annual Report on Form 10-K for the year ended December 31, 2014, are an integral part of the condensed
consolidated financial statements.
2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands) | ||||||||
Net income |
$ | 32,787 | $ | 929 | ||||
|
|
|
|
|||||
Other comprehensive income (loss), net of tax: |
||||||||
Unrealized gains on marketable securities: |
||||||||
Unrealized gains on marketable securities arising during period, net of tax of $704, $654 |
1,799 | 1,139 | ||||||
Less: Reclassification adjustment for gains included in net income, net of tax of $(169), $(102) |
(330 | ) | (176 | ) | ||||
|
|
|
|
|||||
1,469 | 963 | |||||||
Defined benefit pension and post-retirement plans: |
||||||||
Amortization of prior service benefit included in net periodic pension and post-retirement expense/income, net of tax of $(42), $(42) |
(74 | ) | (73 | ) | ||||
|
|
|
|
|||||
Other comprehensive income |
1,395 | 890 | ||||||
|
|
|
|
|||||
Comprehensive income |
$ | 34,182 | $ | 1,819 | ||||
|
|
|
|
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradynes
Annual Report on Form 10-K for the year ended December 31, 2014, are an integral part of the condensed
consolidated financial statements.
3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands) | ||||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 32,787 | $ | 929 | ||||
Adjustments to reconcile net income to net cash provided by (used for) operating activities: |
||||||||
Depreciation |
19,345 | 15,259 | ||||||
Amortization |
15,139 | 23,925 | ||||||
Stock-based compensation |
7,963 | 15,233 | ||||||
Provision for excess and obsolete inventory |
1,440 | 10,039 | ||||||
Gain from the sale of an equity investment |
(4,782 | ) | | |||||
Deferred taxes |
(1,831 | ) | 12,699 | |||||
Other |
(1,417 | ) | (141 | ) | ||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(24,749 | ) | (58,882 | ) | ||||
Inventories |
5,960 | 2,635 | ||||||
Prepayments and other assets |
3,146 | (628 | ) | |||||
Accounts payable and other accrued expenses |
(20,150 | ) | (45,487 | ) | ||||
Deferred revenue and customer advances |
1,038 | 9,632 | ||||||
Retirement plans contributions |
(1,019 | ) | (1,425 | ) | ||||
Accrued income taxes |
4,662 | (9,609 | ) | |||||
|
|
|
|
|||||
Net cash provided by (used for) operating activities |
37,532 | (25,821 | ) | |||||
Cash flows from investing activities: |
||||||||
Purchases of property, plant and equipment |
(21,149 | ) | (31,197 | ) | ||||
Purchases of available-for-sale marketable securities |
(335,635 | ) | (257,260 | ) | ||||
Proceeds from maturities of available-for-sale marketable securities |
140,222 | 280,322 | ||||||
Proceeds from sales of available-for-sale marketable securities |
148,639 | 101,363 | ||||||
Proceeds from the sale of an equity investment |
4,782 | | ||||||
Proceeds from life insurance |
1,098 | 4,391 | ||||||
|
|
|
|
|||||
Net cash (used for) provided by investing activities |
(62,043 | ) | 97,619 | |||||
Cash flows from financing activities: |
||||||||
Issuance of common stock under employee stock purchase and stock option plans |
8,899 | 10,165 | ||||||
Repurchase of common stock |
(46,650 | ) | | |||||
Dividend payments |
(13,049 | ) | | |||||
Payments of long-term debt |
| (190,975 | ) | |||||
|
|
|
|
|||||
Net cash used for financing activities |
(50,800 | ) | (180,810 | ) | ||||
|
|
|
|
|||||
Decrease in cash and cash equivalents |
(75,311 | ) | (109,012 | ) | ||||
Cash and cash equivalents at beginning of period |
294,256 | 341,638 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 218,945 | $ | 232,626 | ||||
|
|
|
|
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradynes
Annual Report on Form 10-K for the year ended December 31, 2014, are an integral part of the condensed
consolidated financial statements.
4
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
A. The Company
Teradyne, Inc. (Teradyne) is a leading global supplier of automatic test equipment. Teradynes automatic test equipment products and services include:
| semiconductor test (Semiconductor Test) systems; |
| wireless test (Wireless Test) systems; and |
| defense/aerospace (Defense/Aerospace) test instrumentation and systems, storage test (Storage Test) systems, and circuit-board test and inspection (Production Board Test) systems (collectively these products represent System Test). |
B. Accounting Policies
Basis of Presentation
The consolidated interim financial statements include the accounts of Teradyne and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair presentation of such interim financial statements. Certain prior year amounts were reclassified to conform to the current year presentation. The December 31, 2014 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in Teradynes Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission (SEC) on February 27, 2015, for the year ended December 31, 2014.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Actual results may differ significantly from these estimates.
C. Recently Issued Accounting Pronouncements
In May 2014, the FASB issued Accounting Standard Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606), which will replace numerous requirements in U.S. GAAP, including industry-specific requirements, and provide companies with a single revenue recognition model for recognizing revenue from contracts with customers. The core principle of the new standard is that a company should recognize revenue to show the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to in exchange for those goods or services. On April 1, 2015, FASB proposed a deferral of the effective date of the new revenue standard by one year, until January 1, 2018. For Teradyne, the standard will be effective in the first quarter of 2018. Early adoption is permitted but not before the original effective date (that is, annual periods beginning after December 15, 2016). The two permitted transition methods under the new standard are the full retrospective method, in which case the standard would be applied to each prior reporting period presented, or the modified retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application. Teradyne has not yet selected a transition method. Teradyne is currently evaluating the impact of this ASU on its financial position and results of operations.
D. ACQUISITIONS
Business
Avionics Interface Technologies, LLC.
On October 31, 2014, Teradyne acquired substantially all of the assets and liabilities of Avionics Interface Technologies, LLC (AIT) located in Omaha, Nebraska. AIT is a supplier of equipment for testing state-of-the-art data communication buses. The acquisition of AIT complements Teradynes Defense/Aerospace line of bus test instrumentation for commercial and defense avionics systems. AIT is included in Teradynes System Test segment.
The total purchase price of $21.2 million consisted of $19.4 million of cash paid to acquire AITs assets and liabilities and $1.8 million in fair value of contingent consideration payable upon achievement of certain revenue and gross margin targets in 2015 and 2016. The maximum amount of contingent consideration that could be paid is $2.1 million.
5
The valuation of the contingent consideration utilized the following assumptions: (1) probability of meeting each target; (2) expected timing of meeting each target; and (3) discount rate reflecting the risk associated with the expected payments. The probabilities and timing for each target were estimated based on a review of the historical and projected results. A discount rate of 4.7 percent was selected based on the estimated cost of debt for the business, as a significant portion of the risk in achieving the contingent consideration was captured in the probabilities assigned to meeting each target.
The AIT acquisition was accounted for as a business combination and, accordingly, the results have been included in Teradynes consolidated results of operations from the date of acquisition. The allocation of the total purchase price to AITs net tangible and identifiable intangible assets was based on their estimated fair values as of the acquisition date. The excess of the purchase price over the identifiable intangible and net tangible assets in the amount of $10.5 million was allocated to goodwill, which is deductible for tax purposes.
The following table represents the allocation of the final purchase price:
Purchase Price Allocation | ||||
(in thousands) | ||||
Goodwill |
$ | 10,516 | ||
Intangible assets |
9,080 | |||
Tangible assets acquired and liabilities assumed: |
||||
Other current assets |
2,452 | |||
Non-current assets |
359 | |||
Accounts payable and current liabilities |
(1,164 | ) | ||
|
|
|||
Total purchase price |
$ | 21,243 | ||
|
|
Teradyne estimated the fair value of intangible assets using the income approach. Acquired intangible assets are amortized on a straight-line basis over their estimated useful lives. Components of these intangible assets and their estimated useful lives at the acquisition date are as follows:
Fair Value | Estimated Useful Life |
|||||||
(in thousands) | (in years) | |||||||
Customer relationships |
$ | 5,630 | 5.0 | |||||
Developed technology |
2,580 | 4.8 | ||||||
Trademark |
380 | 5.0 | ||||||
Non-compete agreement |
320 | 4.0 | ||||||
Customer order backlog |
170 | 0.3 | ||||||
|
|
|||||||
Total intangible assets |
$ | 9,080 | 4.8 | |||||
|
|
E. Financial Instruments and Derivatives
Cash Equivalents
Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.
Marketable Securities
Teradyne accounts for its investments in debt and equity securities in accordance with the provisions of Accounting Standards Codification (ASC) 320-10, InvestmentsDebt and Equity Securities. ASC 320-10 requires that certain debt and equity securities be classified into one of three categories; trading, available-for-sale or held-to-maturity securities. As of April 5, 2015, Teradynes investments in debt and equity securities were classified as available-for-sale and recorded at their fair market value.
On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:
| The length of time and the extent to which the market value has been less than cost; |
| The financial condition and near-term prospects of the issuer; and |
| The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value. |
6
Teradyne uses the market and income approach techniques to value its financial instruments and there were no changes in valuation techniques during the three months ended April 5, 2015. As defined in ASC 820-10 Fair Value Measurements and Disclosures, fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:
Level 1: Quoted prices in active markets for identical assets as of the reporting date.
Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities relationship to other benchmark quoted prices, and is considered a Level 2 input.
Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradynes own data.
Teradynes available-for-sale fixed income securities are classified as Level 2. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.
There were no realized losses recorded in the three months ended April 5, 2015 and March 30, 2014. Realized gains recorded in the three months ended April 5, 2015 and March 30, 2014, were $0.5 million and $0.3 million, respectively. Realized gains are included in interest income. Unrealized gains and losses are included in accumulated other comprehensive income (loss). The cost of securities sold is based on the specific identification method.
During the three months ended April 5, 2015 and March 30, 2014, there were no transfers in or out of Level 1, Level 2 or Level 3 financial instruments.
The following table sets forth by fair value hierarchy Teradynes financial assets and liabilities that were measured at fair value on a recurring basis as of April 5, 2015 and December 31, 2014.
April 5, 2015 | ||||||||||||||||
Quoted Prices in Active Markets for Identical Instruments (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets |
||||||||||||||||
Cash |
$ | 115,982 | $ | | $ | | $ | 115,982 | ||||||||
Cash equivalents |
100,794 | 2,169 | | 102,963 | ||||||||||||
Available-for-sale securities: |
||||||||||||||||
U.S. Treasury securities |
| 427,119 | | 427,119 | ||||||||||||
U.S. government agency securities |
| 232,187 | | 232,187 | ||||||||||||
Corporate debt securities |
| 160,877 | | 160,877 | ||||||||||||
Commercial paper |
| 130,298 | | 130,298 | ||||||||||||
Certificates of deposit and time deposits |
| 87,052 | | 87,052 | ||||||||||||
Equity and debt mutual funds |
13,962 | | | 13,962 | ||||||||||||
Non-U.S. government securities |
| 446 | | 446 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 230,738 | $ | 1,040,148 | $ | | $ | 1,270,886 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities |
||||||||||||||||
Contingent consideration |
$ | | $ | | $ | 3,350 | $ | 3,350 | ||||||||
Derivatives |
| 19 | | 19 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | | $ | 19 | $ | 3,350 | $ | 3,369 | ||||||||
|
|
|
|
|
|
|
|
7
Reported as follows:
(Level 1) | (Level 2) | (Level 3) | Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets |
||||||||||||||||
Cash and cash equivalents |
$ | 216,776 | $ | 2,169 | $ | | $ | 218,945 | ||||||||
Marketable securities |
| 649,219 | | 649,219 | ||||||||||||
Long-term marketable securities |
13,962 | 388,760 | | 402,722 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 230,738 | $ | 1,040,148 | $ | | $ | 1,270,886 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities |
||||||||||||||||
Other accrued liabilities |
$ | | $ | 19 | $ | 3,350 | $ | 3,369 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | | $ | 19 | $ | 3,350 | $ | 3,369 | |||||||||
|
|
|
|
|
|
|
|
December 31, 2014 | ||||||||||||||||
Quoted Prices in Active Markets for Identical Instruments (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets |
||||||||||||||||
Cash |
$ | 111,471 | $ | | $ | | $ | 111,471 | ||||||||
Cash equivalents |
160,218 | 22,567 | | 182,785 | ||||||||||||
Available-for-sale securities: |
||||||||||||||||
U.S. Treasury securities |
| 402,154 | | 402,154 | ||||||||||||
U.S. government agency securities |
| 258,502 | | 258,502 | ||||||||||||
Corporate debt securities |
| 141,467 | | 141,467 | ||||||||||||
Commercial paper |
| 140,638 | | 140,638 | ||||||||||||
Certificates of deposit and time deposits |
| 49,036 | | 49,036 | ||||||||||||
Equity and debt mutual funds |
12,333 | | | 12,333 | ||||||||||||
Non-U.S. government securities |
| 446 | | 446 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 284,022 | $ | 1,014,810 | $ | | $ | 1,298,832 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities |
||||||||||||||||
Contingent consideration |
$ | | $ | | $ | 3,350 | $ | 3,350 | ||||||||
Derivatives |
| 149 | | 149 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | | $ | 149 | $ | 3,350 | $ | 3,499 | ||||||||
|
|
|
|
|
|
|
|
Reported as follows:
(Level 1) | (Level 2) | (Level 3) | Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets |
||||||||||||||||
Cash and cash equivalents |
$ | 271,689 | $ | 22,567 | $ | | $ | 294,256 | ||||||||
Marketable securities |
| 533,787 | | 533,787 | ||||||||||||
Long-term marketable securities |
12,333 | 458,456 | | 470,789 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 284,022 | $ | 1,014,810 | $ | | $ | 1,298,832 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities |
||||||||||||||||
Other current liabilities |
$ | | $ | 149 | $ | 1,750 | $ | 1,899 | ||||||||
Long-term other accrued liabilities |
| | 1,600 | 1,600 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | | $ | 149 | $ | 3,350 | $ | 3,499 | |||||||||
|
|
|
|
|
|
|
|
8
Changes in the fair value of Level 3 contingent consideration for the three months ended April 5, 2015 and March 30, 2014 were as follows:
Contingent Consideration | ||||
(in thousands) | ||||
Balance at December 31, 2013 |
$ | 2,230 | ||
Payments |
| |||
|
|
|||
Balance at March 30, 2014 |
2,230 | |||
Payments |
| |||
|
|
|||
Balance at June 29, 2014 |
2,230 | |||
Fair value adjustment |
(630 | ) | ||
|
|
|||
Balance at September 28, 2014 |
1,600 | |||
Acquisition of AIT |
1,750 | |||
|
|
|||
Balance at December 31, 2014 |
3,350 | |||
Payments |
| |||
|
|
|||
Balance at April 5, 2015 |
$ | 3,350 | ||
|
|
The following table provides quantitative information associated with the fair value measurement of Teradynes Level 3 financial instruments:
Liability |
April 5, 2015 Fair Value |
Valuation Technique |
Unobservable Inputs |
Weighted Average |
||||||||
(in thousands) | ||||||||||||
Contingent consideration (ZTEC) | $ | 1,600 | Income approach- discounted cash flow |
Revenue earn-out-probability for calendar year 2015 revenue |
0 | % | ||||||
Customer orders-probability of achievement during earn-out period (acquisition date through December 31, 2015) |
40 | % | ||||||||||
Discount rate for revenue earn-out |
N/A | |||||||||||
Discount rate for customer orders |
5.2 | % | ||||||||||
Contingent consideration (AIT) |
$ | 1,750 | Income approach- discounted cash flow |
Revenue earn-out-probability for calendar year 2015 and 2016 |
90 | % | ||||||
Discount rate for revenue earn-out | 4.7 | % |
The significant unobservable inputs used in the ZTEC Instruments, Inc. (ZTEC) fair value measurement of contingent consideration are the probabilities of successful achievement of calendar year 2015 revenue and customer orders, and a discount rate. Increases or decreases in the revenue and customer order probabilities and the period in which results will be achieved would result in a higher or lower fair value measurement. The maximum amount of contingent consideration in connection with the acquisition of ZTEC that could be paid is $5.0 million. The earn-out period in connection with the ZTEC acquisition ends on December 31, 2015.
The significant unobservable inputs used in the AIT fair value measurement of contingent considerations are the probabilities of successful achievement of calendar year 2015 and 2016 revenue, and a discount rate. Increases or decreases in the revenue probabilities and the period in which results will be achieved would result in a higher or lower fair value measurement. The maximum amount of contingent consideration in connection with the acquisition of AIT that could be paid is $2.1 million. The earn-out periods in connection with the AIT acquisition end on December 31, 2015 and December 31, 2016, respectively.
9
The carrying amounts and fair values of Teradynes financial instruments at April 5, 2015 and December 31, 2014 were as follows:
April 5, 2015 | December 31, 2014 | |||||||||||||||
Carrying Value | Fair Value | Carrying Value | Fair Value | |||||||||||||
(in thousands) | ||||||||||||||||
Cash and cash equivalents |
$ | 218,945 | $ | 218,945 | $ | 294,256 | $ | 294,256 | ||||||||
Marketable securities |
1,051,941 | 1,051,941 | 1,004,576 | 1,004,576 | ||||||||||||
Contingent consideration |
3,350 | 3,350 | 3,350 | 3,350 | ||||||||||||
Derivatives |
19 | 19 | 149 | 149 |
The fair values of accounts receivable, net and accounts payable approximate the carrying amount due to the short-term nature of these instruments.
The following tables summarize the composition of available-for-sale marketable securities at April 5, 2015 and December 31, 2014:
April 5, 2015 | ||||||||||||||||||||
Available-for-Sale | Fair Market Value of Investments with Unrealized Losses |
|||||||||||||||||||
Cost | Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
|||||||||||||||||
(in thousands) | ||||||||||||||||||||
U.S. Treasury securities |
$ | 426,637 | $ | 625 | $ | (143 | ) | $ | 427,119 | $ | 217,722 | |||||||||
U.S. government agency securities |
231,747 | 443 | (3 | ) | 232,187 | 15,032 | ||||||||||||||
Corporate debt securities |
158,051 | 2,986 | (160 | ) | 160,877 | 51,495 | ||||||||||||||
Commercial paper |
130,227 | 72 | (1 | ) | 130,298 | 8,945 | ||||||||||||||
Certificates of deposit and time deposits |
87,043 | 24 | (15 | ) | 87,052 | 25,705 | ||||||||||||||
Equity and debt mutual funds |
11,823 | 2,147 | (8 | ) | 13,962 | 161 | ||||||||||||||
Non-U.S. government securities |
446 | | | 446 | | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,045,974 | $ | 6,297 | $ | (330 | ) | $ | 1,051,941 | $ | 319,060 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Reported as follows:
Cost | Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
Fair Market Value of Investments with Unrealized Losses |
||||||||||||||||
(in thousands) | ||||||||||||||||||||
Marketable securities |
$ | 649,066 | $ | 224 | $ | (71 | ) | $ | 649,219 | $ | 223,414 | |||||||||
Long-term marketable securities |
396,908 | 6,073 | (259 | ) | 402,722 | 95,646 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,045,974 | $ | 6,297 | $ | (330 | ) | $ | 1,051,941 | $ | 319,060 | ||||||||||
|
|
|
|
|
|
|
|
|
|
December 31, 2014 | ||||||||||||||||||||
Available-for-Sale | Fair Market Value of Investments with Unrealized Losses |
|||||||||||||||||||
Cost | Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
|||||||||||||||||
(in thousands) | ||||||||||||||||||||
U.S. Treasury securities |
$ | 402,197 | $ | 362 | $ | (405 | ) | $ | 402,154 | $ | 317,771 | |||||||||
U.S. government agency securities |
258,452 | 135 | (85 | ) | 258,502 | 104,642 | ||||||||||||||
Corporate debt securities |
139,374 | 2,414 | (321 | ) | 141,467 | 96,998 | ||||||||||||||
Commercial paper |
140,616 | 26 | (4 | ) | 140,638 | 41,747 | ||||||||||||||
Certificates of deposit and time deposits |
49,048 | 11 | (23 | ) | 49,036 | 20,684 | ||||||||||||||
Equity and debt mutual funds |
10,492 | 1,870 | (29 | ) | 12,333 | 1,234 | ||||||||||||||
Non-U.S. government securities |
446 | | | 446 | | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,000,625 | $ | 4,818 | $ | (867 | ) | $ | 1,004,576 | $ | 583,076 | ||||||||||
|
|
|
|
|
|
|
|
|
|
10
Reported as follows:
Cost | Unrealized Gain |
Unrealized (Loss) |
Fair Market Value |
Fair Market Value of Investments with Unrealized Losses |
||||||||||||||||
(in thousands) | ||||||||||||||||||||
Marketable securities |
$ | 533,833 | $ | 99 | $ | (145 | ) | $ | 533,787 | $ | 240,234 | |||||||||
Long-term marketable securities |
466,792 | 4,719 | (722 | ) | 470,789 | 342,842 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,000,625 | $ | 4,818 | $ | (867 | ) | $ | 1,004,576 | $ | 583,076 | ||||||||||
|
|
|
|
|
|
|
|
|
|
As of April 5, 2015, the fair market value of investments with unrealized losses was $319.1 million. Of this value, $0.3 million had unrealized losses greater than one year and $318.8 million had unrealized losses less than one year. As of December 31, 2014, the fair market value of investments with unrealized losses was $583.1 million. Of this value, $2.3 million had unrealized losses greater than one year and $580.8 million had unrealized losses less than one year.
Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments, at April 5, 2015 and December 31, 2014, were temporary.
The contractual maturities of investments held at April 5, 2015 were as follows:
April 5, 2015 | ||||||||
Cost | Fair Market Value |
|||||||
(in thousands) | ||||||||
Due within one year |
$ | 649,066 | $ | 649,219 | ||||
Due after 1 year through 5 years |
343,120 | 343,744 | ||||||
Due after 5 years through 10 years |
5,663 | 5,952 | ||||||
Due after 10 years |
36,302 | 39,064 | ||||||
|
|
|
|
|||||
Total |
$ | 1,034,151 | $ | 1,037,979 | ||||
|
|
|
|
Contractual maturities of investments held at April 5, 2015 exclude equity and debt mutual funds as they do not have contractual maturity dates.
Derivatives
Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradynes foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.
To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in value of the monetary assets and liabilities denominated in foreign currencies.
The notional amount of foreign currency forward contracts was $96.2 million and $73.0 million at April 5, 2015 and December 31, 2014, respectively. The fair value of the outstanding contracts was $0.0 million and a loss of $0.1 million at April 5, 2015 and December 31, 2014, respectively.
11
In the three months ended April 5, 2015 and March 30, 2014, Teradyne recorded net realized losses of $3.4 million and $0.7 million, respectively, related to foreign currency forward contracts hedging net monetary positions. Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.
The following table summarizes the fair value of derivative instruments at April 5, 2015 and December 31, 2014:
Balance Sheet Location | April 5, 2015 |
December 31, 2014 |
||||||||
(in thousands) | ||||||||||
Derivatives not designated as hedging instruments: |
||||||||||
Foreign exchange contracts |
Other current liabilities | $ | 19 | $ | 149 | |||||
|
|
|
|
|||||||
Total derivatives |
$ | 19 | $ | 149 | ||||||
|
|
|
|
Teradyne had no offsetting foreign exchange contracts at April 5, 2015 and December 31, 2014.
The following table summarizes the effect of derivative instruments recognized in the statement of operations during the three months ended April 5, 2015 and March 30, 2014. The table does not reflect the corresponding gains from the remeasurement of the monetary assets and liabilities denominated in foreign currencies. For the three months ended April 5, 2015 and March 30, 2014, gains from the remeasurement of the monetary assets and liabilities denominated in foreign currencies were $4.3 million and $0.6 million, respectively.
For the Three Months Ended |
||||||||||
Location of Losses (Gains) Recognized in Statements of Operations |
April 5, 2015 |
March 30, 2014 |
||||||||
(in thousands) | ||||||||||
Derivatives not designated as hedging instruments: |
||||||||||
Foreign exchange contracts |
Other (income) expense, net | $ | 3,425 | $ | 747 | |||||
|
|
|
|
|||||||
Total derivatives |
$ | 3,425 | $ | 747 | ||||||
|
|
|
|
See Note F: Debt regarding derivatives related to the convertible senior notes.
F. Debt
Loan Agreement
On March 31, 2009, Teradyne K.K., Teradynes wholly-owned subsidiary in Japan, entered into a loan agreement with a local bank in Japan to borrow approximately $10.0 million (the loan was denominated in Japanese Yen). The loan had a term of 5 years and a fixed interest rate of 0.8%. Approximately $6.0 million of the loan was collateralized by a real estate mortgage on Teradyne K.K.s building and land in Kumamoto, Japan and approximately $4.0 million was unsecured. Teradyne, Inc. guaranteed payment of the loan obligation. The principal was amortized over the term of the loan with semiannual principal payments of approximately $1.0 million on September 30 and March 30 each year. The final principal and interest payments were made during the three months ended March 30, 2014.
Convertible Senior Notes
On March 31, 2009, Teradyne entered into an underwriting agreement regarding a public offering of $175.0 million aggregate principal amount of 4.50% convertible senior notes due March 15, 2014 (the Notes). On April 1, 2009, the underwriters exercised their option to purchase an additional $15.0 million aggregate principal amount of the Notes for a total aggregate principal amount of $190.0 million. The Notes bore interest at a rate of 4.50% per annum, payable semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2009. The Notes had a maturity date of March 15, 2014. Substantially all of the Notes were converted prior to March 15, 2014 and were net share settled, meaning that the holders received, for each $1,000 in principal amount of Notes, $1,000 in cash and approximately 131.95 shares of Teradyne common stock (calculated by taking 182.65 shares, being the fixed number specified in the Notes purchase agreement, less 50.7 shares). The 50.7 shares were determined, as specified in the Notes purchase agreement, by dividing the $1,000 principal amount by the $19.74 average trading price of Teradynes common stock over the 25 day trading period from February 5, 2014 to March 12, 2014.
Teradyne satisfied the Notes net share settlement by paying the aggregate principal amount of $190 million in cash and issuing 25.1 million shares of common stock. On March 13, 2014, Teradyne exercised its call option agreement entered into with Goldman, Sachs & Co. (the hedge counterparty) at the time of issuance of the Notes and received 25.1 million shares of Teradynes common stock, which Teradyne retired.
12
From June 17, 2014 to September 17, 2014, the hedge counterparty exercised its warrant agreement entered into with Teradyne at the time of issuance of the Notes. The warrants were net share settled. In 2014, Teradyne issued 21.2 million shares of its common stock for warrants exercised at a weighted average strike price of $7.6348 per share.
The interest expense on Teradynes convertible senior notes for the three months ended April 5, 2015 and March 30, 2014 was as follows:
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands) | ||||||||
Contractual interest expense on the coupon |
$ | | $ | 1,757 | ||||
Amortization of the discount component and debt issue fees recognized as interest expense |
| 4,493 | ||||||
|
|
|
|
|||||
Total interest expense on the convertible debt |
$ | | $ | 6,250 | ||||
|
|
|
|
G. Prepayments
Prepayments consist of the following and are included in prepayments on the balance sheet:
April 5, 2015 |
December 31, 2014 |
|||||||
(in thousands) | ||||||||
Contract manufacturer prepayments |
$ | 62,439 | $ | 65,972 | ||||
Prepaid taxes |
10,375 | 11,462 | ||||||
Prepaid maintenance and other services |
7,056 | 7,343 | ||||||
Other prepayments |
12,614 | 11,042 | ||||||
|
|
|
|
|||||
Total prepayments |
$ | 92,484 | $ | 95,819 | ||||
|
|
|
|
H. Deferred Revenue and Customer Advances
Deferred revenue and customer advances consist of the following and are included in short and long-term deferred revenue and customer advances on the balance sheet:
April 5, 2015 |
December 31, 2014 |
|||||||
(in thousands) | ||||||||
Extended warranty |
$ | 40,704 | $ | 43,300 | ||||
Product maintenance and training |
29,820 | 30,500 | ||||||
Customer advances |
8,884 | 8,875 | ||||||
Undelivered elements and other |
13,162 | 8,857 | ||||||
|
|
|
|
|||||
Total deferred revenue and customer advances |
$ | 92,570 | $ | 91,532 | ||||
|
|
|
|
I. Product Warranty
Teradyne generally provides a one-year warranty on its products, commencing upon installation, acceptance or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience. Related costs are charged to the warranty accrual as incurred. The warranty balance below is included in other accrued liabilities on the balance sheet.
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands) | ||||||||
Balance at beginning of period |
$ | 8,942 | $ | 6,660 | ||||
Accruals for warranties issued during the period |
2,361 | 2,858 | ||||||
Adjustments related to pre-existing warranties |
(1,031 | ) | (140 | ) | ||||
Settlements made during the period |
(2,849 | ) | (2,763 | ) | ||||
|
|
|
|
|||||
Balance at end of period |
$ | 7,423 | $ | 6,615 | ||||
|
|
|
|
13
When Teradyne receives revenue for extended warranty beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The extended warranty balance below is included in short and long-term deferred revenue and customer advances on the balance sheet.
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands) | ||||||||
Balance at beginning of period |
$ | 43,300 | $ | 34,909 | ||||
Deferral of new extended warranty revenue |
4,204 | 2,361 | ||||||
Recognition of extended warranty deferred revenue |
(6,800 | ) | (3,321 | ) | ||||
|
|
|
|
|||||
Balance at end of period |
$ | 40,704 | $ | 33,949 | ||||
|
|
|
|
J. Stock-Based Compensation
Commencing in January 2014, Teradyne granted performance-based restricted stock units (PRSUs) to its executive officers with a performance metric based on relative total shareholder return (TSR). Teradynes three-year TSR performance will be measured against the Philadelphia Semiconductor Index, which consists of thirty companies in the semiconductor device and capital equipment industries. The final number of TSR PRSUs that vest will vary based upon the level of performance achieved from 200% of the target shares to 0% of the target shares. The TSR PRSUs will vest upon the three-year anniversary of the grant date. Beginning with PRSUs granted in January 2014, if the recipients employment ends prior to the determination of the performance percentage due to (1) permanent disability or death or (2) retirement or termination other than for cause, after attaining both at least age sixty and at least ten years of service, then all or a portion of the recipients PRSUs (based on the actual performance percentage achieved on the determination date) will vest on the date the performance percentage is determined. Except as set forth in the preceding sentence, no TSR PRSUs will vest if the executive officer is no longer an employee at the end of the three-year period.
The TSR PRSUs are valued using a Monte Carlo simulation model. The number of units expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the three-year service period. Compensation expense is recognized regardless of the eventual number of units that are earned based upon the market condition, provided the executive officer remains an employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period the executive officer is no longer an employee, subject to the retirement and termination eligibility provisions noted above.
During the three months ended April 5, 2015 and March 30, 2014, Teradyne granted 0.2 million and 0.1 million, respectively, TSR PRSUs with a grant date fair value of $18.21 and $22.06, respectively. The fair value was estimated using the Monte Carlo simulation model with the following assumptions:
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
Risk-free interest rate |
0.77 | % | 0.75 | % | ||||
Teradyne volatility-historical |
28.2 | % | 36.1 | % | ||||
Philadelphia Semiconductor Index volatility-historical |
19.7 | % | 24.6 | % | ||||
Dividend yield |
1.33 | % | 1.25 | % |
Expected volatility was based on the historical volatility of Teradynes stock and the Philadelphia Semiconductor Index over the most recent three year period. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.24 per share divided by Teradynes stock price on the grant date of $18.10 for 2015 grants and $19.16 for 2014 grants.
14
During the three months ended April 5, 2015, Teradyne granted 1.4 million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $17.14 and 0.1 million of service-based stock options to executive officers at a weighted average grant date fair value of $4.43.
During the three months ended March 30, 2014, Teradyne granted 1.6 million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $18.19 and 0.1 million of service-based stock options to executive officers at a weighted average grant date fair value of $5.49.
Restricted stock unit awards granted to employees vest in equal annual installments over four years. Stock options vest in equal annual installments over four years, and have a term of seven years from the date of grant.
The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
Expected life (years) |
4.0 | 4.0 | ||||||
Risk-free interest rate |
1.1 | % | 1.2 | % | ||||
Volatility-historical |
33.4 | % | 38.8 | % | ||||
Dividend yield |
1.33 | % | 1.25 | % |
Teradyne determined the stock options expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.24 per share divided by Teradynes stock price on the grant date, of $18.10 for 2015 grants and $19.16 for 2014 grants.
Effective January 31, 2014, Michael Bradley retired as Chief Executive Officer of Teradyne. On January 22, 2014, Teradyne entered into an agreement (the Retirement Agreement) with Mr. Bradley. Under the Retirement Agreement, Mr. Bradleys unvested restricted stock units and stock options granted prior to his retirement date will continue to vest in accordance with their terms through January 31, 2017; and any vested options or options that vest during that period may be exercised for the remainder of the applicable option term. In the Retirement Agreement, Mr. Bradley agreed to be bound by non-competition and non-solicitation restrictions through January 31, 2017. Mr. Bradley continues to serve on Teradynes Board of Directors. In the three months ended March 30, 2014, Teradyne recorded a one-time charge to stock-based compensation expense of $6.6 million related to the Retirement Agreement.
K. Accumulated Other Comprehensive Income
Changes in accumulated other comprehensive income, which is presented net of tax, consist of the following:
For the Three Months Ended April 5, 2015 |
||||||||||||
Unrealized Gains on Marketable Securities |
Retirement Plans Prior Service Credit |
Total | ||||||||||
(in thousands) | ||||||||||||
Balance at December 31, 2014, net of tax of $1,598, $(453) |
$ | 2,365 | $ | 2,324 | $ | 4,689 | ||||||
|
|
|
|
|
|
|||||||
Other comprehensive income before reclassifications, net of tax of $704 |
1,799 | | 1,799 | |||||||||
Amounts reclassified from accumulated other comprehensive income, net of tax of $(169), $(42) |
(330 | ) | (74 | ) | (404 | ) | ||||||
|
|
|
|
|
|
|||||||
Net current period other comprehensive income, net of tax of $535, $(42) |
1,469 | (74 | ) | 1,395 | ||||||||
|
|
|
|
|
|
|||||||
Balance at April 5, 2015, net of tax of $2,133, $(495) |
$ | 3,834 | $ | 2,250 | $ | 6,084 | ||||||
|
|
|
|
|
|
15
For the Three Months Ended March 30, 2014 |
||||||||||||
Unrealized Gains on Marketable Securities |
Retirement Plans Prior Service Credit |
Total | ||||||||||
(in thousands) | ||||||||||||
Balance at December 31, 2013, net of tax of $794, $(284) |
$ | 1,381 | $ | 2,619 | $ | 4,000 | ||||||
|
|
|
|
|
|
|||||||
Other comprehensive income before reclassifications, net of tax of $654 |
1,139 | | 1,139 | |||||||||
Amounts reclassified from accumulated other comprehensive income, net of tax of $(102), $(42) |
(176 | ) | (73 | ) | (249 | ) | ||||||
|
|
|
|
|
|
|||||||
Net current period other comprehensive income, net of tax of $552, $(42) |
963 | (73 | ) | 890 | ||||||||
|
|
|
|
|
|
|||||||
Balance at March 30, 2014, net of tax of $1,346, $(326) |
$ | 2,344 | $ | 2,546 | $ | 4,890 | ||||||
|
|
|
|
|
|
Reclassifications out of accumulated other comprehensive income to the statement of operations for the three months ended April 5, 2015 and March 30, 2014, were as follows:
Details about Accumulated Other Comprehensive Income Components |
For the Three Months Ended | Affected Line Item in the Statements of Operations | ||||||||
April 5, 2015 |
March 30, 2014 |
|||||||||
(in thousands) | ||||||||||
Available-for-sale marketable securities: |
||||||||||
Unrealized gains, net of tax of $169, $102 |
$ | 330 | $ | 176 | Interest income | |||||
Amortization of defined benefit pension and postretirement plans: |
||||||||||
Prior service benefit, net of tax of $42, $42 |
74 | 73 | (a) | |||||||
|
|
|
|
|||||||
Total reclassifications, net of tax of $211, $144 |
$ | 404 | $ | 249 | Net income | |||||
|
|
|
|
(a) | The amortization of prior service benefit is included in the computation of net periodic pension cost and postretirement benefit; see Note N: Retirement Plans. |
L. Intangible Assets
Amortizable intangible assets consist of the following and are included in intangible assets, net on the balance sheet:
April 5, 2015 | ||||||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
Weighted Average Useful Life |
|||||||||||||
(in thousands) | ||||||||||||||||
Developed technology |
$ | 345,513 | $ | 233,749 | $ | 111,764 | 6.2 years | |||||||||
Customer relationships |
146,635 | 97,192 | 49,443 | 7.7 years | ||||||||||||
Tradenames and trademarks |
30,414 | 15,109 | 15,305 | 9.0 years | ||||||||||||
Non-compete agreement |
320 | 40 | 280 | 4.0 years | ||||||||||||
Customer order backlog |
170 | 170 | | 0.3 years | ||||||||||||
|
|
|
|
|
|
|||||||||||
Total intangible assets |
$ | 523,052 | $ | 346,260 | $ | 176,792 | 6.8 years | |||||||||
|
|
|
|
|
|
December 31, 2014 | ||||||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
Weighted Average Useful Life |
|||||||||||||
(in thousands) | ||||||||||||||||
Developed technology |
$ | 345,513 | $ | 224,059 | $ | 121,454 | 6.2 years | |||||||||
Customer relationships |
146,635 | 93,998 | 52,637 | 7.7 years | ||||||||||||
Tradenames and trademarks |
30,414 | 14,205 | 16,209 | 9.0 years | ||||||||||||
Non-compete agreement |
320 | 20 | 300 | 4.0 years | ||||||||||||
Customer order backlog |
170 | 170 | | 0.3 years | ||||||||||||
|
|
|
|
|
|
|||||||||||
Total intangible assets |
$ | 523,052 | $ | 332,452 | $ | 190,600 | 6.8 years | |||||||||
|
|
|
|
|
|
16
Aggregate intangible asset amortization expense was $13.8 million and $18.3 million, respectively, for the three months ended April 5, 2015 and March 30, 2014. Estimated intangible asset amortization expense for each of the five succeeding fiscal years is as follows:
Year |
Amortization Expense | |||
(in thousands) | ||||
2015 (remainder) |
$ | 41,423 | ||
2016 |
55,231 | |||
2017 |
49,046 | |||
2018 |
24,405 | |||
2019 |
4,889 | |||
Thereafter |
1,798 |
M. Net Income per Common Share
The following table sets forth the computation of basic and diluted net income per common share:
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands, except per share amounts) |
||||||||
Net income for basic and diluted net income per share |
$ | 32,787 | $ | 929 | ||||
|
|
|
|
|||||
Weighted average common shares-basic |
217,187 | 193,311 | ||||||
Effect of dilutive potential common shares: |
||||||||
Incremental shares from assumed conversion of convertible notes (1) |
| 20,052 | ||||||
Convertible note hedge warrant shares (2) |
| 20,942 | ||||||
Restricted stock units |
901 | 1,051 | ||||||
Stock options |
696 | 1,106 | ||||||
Employee stock purchase plan |
28 | 22 | ||||||
|
|
|
|
|||||
Dilutive potential common shares |
1,625 | 43,173 | ||||||
|
|
|
|
|||||
Weighted average common shares-diluted |
218,812 | 236,484 | ||||||
|
|
|
|
|||||
Net income per common share-basic |
$ | 0.15 | $ | 0.00 | ||||
|
|
|
|
|||||
Net income per common share-diluted |
$ | 0.15 | $ | 0.00 | ||||
|
|
|
|
(1) | Incremental shares from the assumed conversion of the convertible notes were calculated using the difference between the average Teradyne stock price for the period and the conversion price of $5.48, multiplied by 34.7 million shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period. |
(2) | Convertible note hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price of $7.6650, multiplied by 34.7 million shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period. Teradynes call option on its common stock (convertible note hedge transaction) was excluded from the calculation of diluted shares because the effect was anti-dilutive. See Note F: Debt regarding the convertible note hedge transaction. |
The computation of diluted net income per common share for the three months ended April 5, 2015 excludes the effect of the potential exercise of stock options to purchase approximately 0.2 million shares because the effect would have been anti-dilutive.
The computation of diluted net income per common share for the three months ended March 30, 2014 excludes the effect of the potential exercise of stock options to purchase approximately 0.4 million shares because the effect would have been anti-dilutive.
N. Retirement Plans
ASC 715, CompensationRetirement Benefits requires an employer with defined benefit plans or other postretirement benefit plans to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plans. The pension asset or liability represents a difference between the fair value of the pension plans assets and the projected benefit obligation.
17
Defined Benefit Pension Plans
Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain non-U.S. subsidiaries. Benefits under these plans are based on employees years of service and compensation. Teradynes funding policy is to make contributions to these plans in accordance with local laws and to the extent that such contributions are tax deductible. The assets of these plans consist primarily of fixed income and equity securities. In addition, Teradyne has an unfunded supplemental executive defined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act (ERISA) and the Internal Revenue Code (IRC), as well as unfunded foreign plans.
In the three months ended April 5, 2015, Teradyne contributed $0.6 million to the U.S. supplemental executive defined benefit pension plan and $0.2 million to certain qualified plans for non-U.S. subsidiaries.
For the three months ended April 5, 2015 and March 30, 2014, Teradynes net periodic pension cost was comprised of the following:
For the Three Months Ended | ||||||||||||||||
April 5, 2015 | March 30, 2014 | |||||||||||||||
United States |
Foreign | United States |
Foreign | |||||||||||||
(in thousands) | ||||||||||||||||
Service cost |
$ | 616 | $ | 247 | $ | 546 | $ | 250 | ||||||||
Interest cost |
3,282 | 358 | 3,215 | 505 | ||||||||||||
Expected return on plan assets |
(3,624 | ) | (195 | ) | (3,126 | ) | (216 | ) | ||||||||
Amortization of prior service cost |
33 | | 34 | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net periodic pension cost |
$ | 307 | $ | 410 | $ | 669 | $ | 539 | ||||||||
|
|
|
|
|
|
|
|
Postretirement Benefit Plan
In addition to receiving pension benefits, U.S. Teradyne employees who meet early retirement eligibility requirements as of their termination dates may participate in Teradynes Welfare Plan, which includes death, medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees survivors and are available to all retirees. Substantially all of Teradynes current U.S. employees could become eligible for these benefits, and the existing benefit obligation relates primarily to those employees.
For the three months ended April 5, 2015 and March 30, 2014, Teradynes net periodic postretirement benefit income was comprised of the following:
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in thousands) | ||||||||
Service cost |
$ | 12 | $ | 13 | ||||
Interest cost |
59 | 86 | ||||||
Amortization of prior service benefit |
(149 | ) | (150 | ) | ||||
|
|
|
|
|||||
Total net periodic postretirement benefit income |
$ | (78 | ) | $ | (51 | ) | ||
|
|
|
|
O. Commitments and Contingencies
Purchase Commitments
As of April 5, 2015, Teradyne had entered into purchase commitments for certain components and materials. The purchase commitments covered by the agreements aggregate to approximately $189.5 million, of which $180.8 million is for less than one year.
Legal Claims
Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on Teradynes results of operations, financial condition or cash flows.
18
P. Income Taxes
For the three months ended April 5, 2015, Teradyne had income before income taxes of $42.4 million and recognized income tax expense of $9.7 million resulting in an effective tax rate of 22.7%. The tax rate was lower than the expected federal statutory rate of 35% primarily because of the favorable effect of statutory rates applicable to income earned outside the United States which reduced the projected annual effective tax rate below the expected statutory rate of 35%. The tax rate was reduced further by a $0.5 million discrete tax benefit related to disqualifying dispositions of incentive stock options and employee stock purchase plan shares and a $1.2 million discrete tax benefit related to non-taxable foreign exchange gains.
For the three months ended March 30, 2014, Teradyne had a loss before income taxes of $1.9 million and recognized an income tax benefit of $2.8 million resulting in an effective tax rate of 149.6%. The tax rate for the three months ended March 30, 2014 was higher than the expected statutory rate of 35% primarily as a result of a $1.0 million discrete tax benefit related to disqualifying dispositions of incentive stock options and employee stock purchase plan shares and a $1.0 million discrete tax benefit related to decreases in uncertain tax positions resulting from changes in positions and the expiration of statutes.
On a quarterly basis, Teradyne evaluates the realizability of the deferred tax assets by jurisdiction and assesses the need for a valuation allowance. At April 5, 2015, Teradyne believes that it will ultimately realize the deferred tax assets recorded on the condensed consolidated balance sheet. However, should Teradyne believe that it is more likely than not that the deferred tax assets would not be realized, the tax provision would increase in the period in which Teradyne determined that the realizability was not likely. Teradyne considers the probability of future taxable income and historical profitability, among other factors, in assessing the realizability of the deferred tax assets.
As of April 5, 2015 and December 31, 2014, Teradyne had $30.3 million and $30.4 million, respectively, of reserves for uncertain tax positions. The $0.1 million net decrease in reserves for uncertain tax positions relates to the expiration of statutes of limitations. As of April 5, 2015, Teradyne anticipated the liability for uncertain tax positions could decrease by approximately $0.7 million over the next twelve months, primarily as a result of the expiration of statutes of limitations and settlements with tax authorities. The potential decrease is primarily related to transfer pricing exposures and research credits.
Teradyne recognizes interest and penalties related to income tax matters in income tax expense. As of April 5, 2015 and December 31, 2014, $0.6 million of interest and penalties was included in the reserve for uncertain tax positions.
Teradyne qualifies for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings due to the tax holiday for the three months ended April 5, 2015 was $1.1 million. The impact of the tax holiday on earnings per share was not material. For the three months ended March 30, 2014, there was no incremental benefit from the tax holiday. The tax holiday is currently expected to expire on December 31, 2015. Teradyne is in discussion with the Singapore Economic Development Board with respect to extension of the tax holiday for periods after December 31, 2015.
Q. Segment Information
Teradyne has three operating segments (Semiconductor Test, Wireless Test and System Test), which are its reportable segments. The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The Wireless Test segment includes operations related to the design, manufacturing and marketing of wireless test products and services. The System Test segment includes operations related to the design, manufacturing and marketing of products and services for defense/aerospace instrumentation test, storage test and circuit-board test. Each operating segment has a segment manager who is directly accountable to and maintains regular contact with Teradynes chief operating decision maker (Teradynes chief executive officer) to discuss operating activities, financial results, forecasts, and plans for the segment.
19
Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income before income taxes. The accounting policies of the business segments are the same as those described in Note B: Accounting Policies in Teradynes Annual Report on Form 10-K for the year ended December 31, 2014.
Segment information for the three months ended April 5, 2015 and March 30, 2014 is as follows:
Semiconductor Test |
Wireless Test |
System Test |
Corporate and Eliminations |
Consolidated | ||||||||||||||||
(in thousands) | ||||||||||||||||||||
Three months ended April 5, 2015: |
||||||||||||||||||||
Revenues |
$ | 270,917 | $ | 34,048 | $ | 37,436 | $ | | $ | 342,401 | ||||||||||
Income (loss) before taxes (1)(2) |
43,125 | (10,441 | ) | 1,005 | 8,749 | 42,438 | ||||||||||||||
Three months ended March 30, 2014: |
||||||||||||||||||||
Revenues |
$ | 261,737 | $ | 21,210 | $ | 38,063 | $ | | $ | 321,010 | ||||||||||
Income (loss) before taxes (1)(2) |
34,600 | (25,085 | ) | 448 | (11,836 | ) | (1,873 | ) |
(1) | Interest income, interest expense, and other (income) expense, net are included in Corporate and Eliminations. |
(2) | Included in the income (loss) before income taxes for each of the segments are charges related to inventory and other. |
Included in the Semiconductor Test segment are charges and credits in the following line item in the statements of operations:
For the Three Months Ended |
||||||||
April 5, 2015 | March 30, 2014 | |||||||
(in thousands) | ||||||||
Cost of revenues - inventory charge |
$ | 531 | $ | 6,205 |
Included in the Wireless Test segment are charges and credits in the following line item in the statements of operations:
For the Three Months Ended |
||||||||
April 5, 2015 | March 30, 2014 | |||||||
(in thousands) | ||||||||
Cost of revenues - inventory charge |
$ | 846 | $ | 3,093 |
Included in the System Test segment are charges and credits in the following line item in the statements of operations:
For the Three Months Ended |
||||||||
April 5, 2015 | March 30, 2014 | |||||||
(in thousands) | ||||||||
Cost of revenues - inventory charge |
$ | 63 | $ | 741 |
Included in Corporate and Eliminations are charges and credits in the following line items in the statements of operations:
For the Three Months Ended |
||||||||
April 5, 2015 | March 30, 2014 | |||||||
(in thousands) | ||||||||
Other (income) expense, net - gain from the sale of an equity investment |
$ | (4,782 | ) | $ | | |||
Selling and administrative - stock-based compensation charge (1) |
| 6,598 |
(1) | See Note J: Stock-Based Compensation regarding the stock-based compensation charge. |
R. Shareholders Equity
Stock Repurchase Program
In January 2015, the Board of Directors authorized Teradyne to repurchase up to $500 million of common stock, $300 million of which Teradyne intends to repurchase in 2015. The cumulative repurchases as of April 5, 2015 totaled 2.4 million shares of common stock for $46.7 million at an average price of $19.40 per share.
20
Dividend
Holders of Teradynes common stock are entitled to receive dividends when they are declared by Teradynes Board of Directors.
In January 2015, Teradynes Board of Directors declared a quarterly cash dividend of $0.06 per share that was paid on March 24, 2015 to shareholders of record as of February 27, 2015. Dividend payments for the three months ended April 5, 2015 were $13.0 million.
In January 2014, Teradynes Board of Directors declared an initial quarterly cash dividend of $0.06 per share that was paid on June 2, 2014 to shareholders of record as of May 9, 2014.
While Teradyne declared a quarterly cash dividend and authorized a share repurchase program, it may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of Teradynes Board of Directors which will consider, among other things, Teradynes earnings, capital requirements and financial condition.
S. Subsequent Events
On April 27, 2015, Teradyne entered into a credit agreement (the Credit Agreement) with Barclays Bank PLC, as administrative agent and collateral agent, and the lenders party thereto. The Credit Agreement provides for a five-year, senior secured revolving credit facility of $350.0 million (the Credit Facility). The Credit Agreement further provides that, subject to customary conditions, Teradyne may seek to obtain from existing or new lenders incremental commitments under the Credit Facility in an aggregate principal amount not to exceed $150.0 million.
Proceeds from the Credit Facility may be used for general corporate purposes and working capital. As of May 8, 2015, Teradyne has not borrowed any funds under the Credit Facility.
The interest rates applicable to loans under the Credit Facility are, at Teradynes option, equal to either a base rate plus a margin ranging from 0.00% to 1.00% per annum or LIBOR plus a margin ranging from 1.00% to 2.00% per annum, based on the consolidated leverage ratio of Teradyne and its restricted subsidiaries. In addition, Teradyne will pay a commitment fee on the unused portion of the commitments under the Credit Facility ranging from 0.125% to 0.350% per annum, based on the then applicable consolidated leverage ratio.
Teradyne is not required to repay any loans under the Credit Facility prior to maturity, subject to certain customary exceptions. Teradyne is permitted to prepay all or any portion of the loans under the Credit Facility prior to maturity without premium or penalty, other than customary LIBOR breakage costs.
The Credit Agreement contains customary events of default, representations, warranties and affirmative and negative covenants that, among other things, limit Teradynes and its Restricted Subsidiaries ability to sell assets, grant liens on assets, incur other secured indebtedness and make certain investments and restricted payments, all subject to exceptions set forth in the Credit Agreement. The Credit Agreement also requires Teradyne to satisfy two financial ratios measured as of the end of each fiscal quarter: a consolidated leverage ratio and an interest coverage ratio.
The Credit Facility is guaranteed by certain of Teradynes domestic subsidiaries and collateralized by assets of Teradyne and such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries.
21
Item 2: | Managements Discussion and Analysis of Financial Condition and Results of Operations |
Statements in this Quarterly Report on Form 10-Q which are not historical facts, so called forward looking statements, are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward looking statements involve risks and uncertainties, including those detailed in our filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form 10-Q and Part I, Item 1A Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2014. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect managements analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.
Overview
We are a leading global supplier of automatic test equipment. We design, develop, manufacture and sell automatic test systems and solutions used to test semiconductors, wireless products, hard disk drives and circuit boards in the consumer electronics, wireless, automotive, industrial, computing, communications and aerospace and defense industries. Our automatic test equipment products and services include:
| semiconductor test (Semiconductor Test) systems; |
| wireless test (Wireless Test) systems; and |
| defense/aerospace (Defense/Aerospace) test instrumentation and systems, storage test (Storage Test) systems, and circuit-board test and inspection (Production Board Test) systems (collectively these products represent System Test). |
We have a broad customer base which includes integrated device manufacturers (IDMs), outsourced semiconductor assembly and test providers (OSATs), wafer foundries, fabless companies that design, but contract with others for the manufacture of integrated circuits (ICs), developers of wireless devices and consumer electronics, manufacturers of circuit boards, automotive suppliers, wireless product manufacturers, storage device manufacturers, aerospace and military contractors.
In October 2014, we acquired Avionics Interface Technologies, LLC (AIT), a supplier of equipment for testing state-of-the-art data communication buses. The acquisition of AIT complements our Defense/Aerospace line of bus test instrumentation for commercial and defense avionics systems. AIT is included in our System Test segment.
We believe our recent acquisitions have enhanced our opportunities for growth. We will continue to invest in our business, grow market share in our markets and expand further our addressable markets while tightly managing our costs.
The sales of our products and services are dependent, to a large degree, on customers who are subject to cyclical trends in the demand for their products. These cyclical periods have had, and will continue to have, a significant effect on our business since our customers often delay or accelerate purchases in reaction to changes in their businesses and to demand fluctuations in the semiconductor and electronics industries. Historically, these demand fluctuations have resulted in significant variations in our results of operations. The sharp swings in the semiconductor and electronics industries in recent years have generally affected the semiconductor and electronics test equipment and services industries more significantly than the overall capital equipment sector.
In the fourth quarter of 2014, we performed our annual goodwill impairment test and recorded a goodwill impairment charge of $98.9 million in our Wireless Test segment as a result of decreased projected demand attributable to an estimated smaller future wireless test market due to reuse of wireless test equipment, price competition and different testing techniques. Further reductions in the size of the wireless test market may occur, which may result in additional goodwill impairment charges, increased risk of excess and obsolete inventories, asset write-offs and restructuring charges.
Critical Accounting Policies and Estimates
We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the three months ended April 5, 2015 to the items disclosed as our critical accounting policies and estimates in Managements Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.
22
SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
Percentage of revenues: |
||||||||
Revenues: |
||||||||
Products |
80 | % | 80 | % | ||||
Services |
20 | 20 | ||||||
|
|
|
|
|||||
Total revenues |
100 | 100 | ||||||
Cost of revenues: |
||||||||
Cost of products |
35 | 39 | ||||||
Cost of services |
9 | 9 | ||||||
|
|
|
|
|||||
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) |
44 | 48 | ||||||
|
|
|
|
|||||
Gross profit |
56 | 52 | ||||||
Operating expenses: |
||||||||
Engineering and development |
21 | 21 | ||||||
Selling and administrative |
21 | 24 | ||||||
Acquired intangible assets amortization |
4 | 6 | ||||||
|
|
|
|
|||||
Total operating expenses |
46 | 51 | ||||||
|
|
|
|
|||||
Income from operations |
10 | 1 | ||||||
Non-operating (income) expenses: |
||||||||
Interest income |
(1 | ) | | |||||
Interest expense |
| 2 | ||||||
Other (income) expense, net |
(2 | ) | | |||||
|
|
|
|
|||||
Income (loss) before income taxes |
12 | (1 | ) | |||||
Income tax provision (benefit) |
3 | (1 | ) | |||||
|
|
|
|
|||||
Net income |
10 | % | | % | ||||
|
|
|
|
Results of Operations
First Quarter 2015 Compared to First Quarter 2014
Book to Bill Ratio
Book to bill ratio is calculated as net bookings divided by net sales. Book to bill ratio by reportable segment was as follows:
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
Semiconductor Test |
1.5 | 1.4 | ||||||
Wireless Test |
0.8 | 2.7 | ||||||
System Test |
1.8 | 0.7 | ||||||
Total Company |
1.4 | 1.4 |
23
Revenues
Revenues by our three reportable segments were as follows:
For the Three Months Ended |
Dollar Change |
|||||||||||
April 5, 2015 |
March 30, 2014 |
|||||||||||
(in millions) | ||||||||||||
Semiconductor Test |
$ | 270.9 | $ | 261.7 | $ | 9.2 | ||||||
Wireless Test |
34.1 | 21.2 | 12.9 | |||||||||
System Test |
37.4 | 38.1 | (0.7 | ) | ||||||||
|
|
|
|
|
|
|||||||
$ | 342.4 | $ | 321.0 | $ | 21.4 | |||||||
|
|
|
|
|
|
The increase in Semiconductor Test revenues of $9.2 million, or 4%, from the three months ended March 30, 2014 to the three months ended April 5, 2015, was primarily due to higher system-on-a-chip (SOC) product sales. The increase in Wireless Test revenue of $12.9 million, or 61%, was primarily driven by higher cellular system sales. The decrease in System Test revenue of $0.7 million, or 2%, was primarily due to lower sales of Storage Test systems.
Revenues by country as a percentage of total revenues were as follows (1):
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
Taiwan |
30 | % | 27 | % | ||||
United States |
14 | 14 | ||||||
China |
13 | 14 | ||||||
Korea |
13 | 7 | ||||||
Japan |
7 | 7 | ||||||
Europe |
6 | 7 | ||||||
Malaysia |
5 | 5 | ||||||
Singapore |
5 | 11 | ||||||
Philippines |
3 | 3 | ||||||
Thailand |
2 | 3 | ||||||
Rest of World |
2 | 2 | ||||||
|
|
|
|
|||||
100 | % | 100 | % | |||||
|
|
|
|
(1) | Revenues attributable to a country are based on location of customer site. |
Gross Profit
Our gross profit was as follows:
For the Three Months Ended |
Dollar/Point Change |
|||||||||||
April 5, 2015 |
March 30, 2014 |
|||||||||||
(in millions) | ||||||||||||
Gross Profit |
$ | 192.4 | $ | 167.0 | $ | 25.4 | ||||||
Percent of Total Revenues |
56.2 | % | 52.0 | % | 4.2 |
Gross profit as a percent of revenue increased by 4.2 points from the three months ended March 30, 2014 to the three months ended April 5, 2015. This increase was a result of an increase of 2.9 points related to product mix in Semiconductor Test and higher Wireless Test sales, an increase of 2.7 points due to lower excess and obsolete inventory provisions, partially offset by higher warranty costs.
24
We assess the carrying value of our inventory on a quarterly basis by estimating future demand and comparing that demand against on-hand and on-order inventory positions. Forecasted revenue information is obtained from the sales and marketing groups and incorporates factors such as backlog and future revenue demand. This quarterly process identifies obsolete and excess inventory. Obsolete inventory, which represents items for which there is no demand, is fully reserved. Excess inventory, which represents inventory items that are not expected to be consumed during the next twelve quarters, is written-down to estimated net realizable value.
During the three months ended April 5, 2015, we recorded an inventory provision of $1.4 million included in cost of revenues primarily due to downward revisions to previously forecasted demand levels. Of the $1.4 million of total excess and obsolete provisions, $0.8 million was related to Wireless Test, $0.5 million was related to Semiconductor Test, and $0.1 million was related to System Test.
During the three months ended March 30, 2014, we recorded an inventory provision of $10.0 million included in cost of revenues of which $6.1 million related to product transitions in Semiconductor Test and $3.9 million due to downward revisions to previously forecasted demand levels. Of the $10.0 million of total excess and obsolete provisions, $6.2 million was related to Semiconductor Test, $3.1 million was related to Wireless Test, and $0.7 million was related to System Test.
During the three months ended April 5, 2015 and March 30, 2014, we scrapped $0.6 million and $0.9 million of inventory, respectively. During the three months ended April 5, 2015 and March 30, 2014, we sold $1.9 million and $1.4 million of previously written-down or written-off inventory. As of April 5, 2015, we had inventory related reserves for inventory which had been written-down or written-off totaling $110.9 million. We have no pre-determined timeline to scrap the remaining inventory.
Engineering and Development
Engineering and development expenses were as follows:
For the Three Months Ended |
Dollar Change |
|||||||||||
April 5, 2015 |
March 30, 2014 |
|||||||||||
(in millions) | ||||||||||||
Engineering and Development |
$ | 71.5 | $ | 67.1 | $ | 4.4 | ||||||
Percent of Total Revenues |
20.9 | % | 20.9 | % |
The increase of $4.4 million in engineering and development expenses from the three months ended March 30, 2014 to the three months ended April 5, 2015 was due primarily to increased spending in Semiconductor Test and higher variable compensation.
Selling and Administrative
Selling and administrative expenses were as follows:
For the Three Months Ended |
Dollar Change |
|||||||||||
April 5, 2015 |
March 30, 2014 |
|||||||||||
(in millions) | ||||||||||||
Selling and Administrative |
$ | 72.0 | $ | 78.0 | $ | (6.0 | ) | |||||
Percent of Total Revenues |
21.0 | % | 24.3 | % |
The decrease of $6.0 million in selling and administrative expenses from the three months ended March 30, 2014 to the three months ended April 5, 2015 was primarily due to a one-time $6.6 million stock-based compensation charge in 2014 related to Michael Bradleys (retired Chief Executive Officer) Retirement Agreement, partially offset by higher variable compensation.
Income Taxes
For the three months ended April 5, 2015, we had income before income taxes of $42.4 million and recognized income tax expense of $9.7 million resulting in an effective tax rate of 22.7%. For the three months ended March 30, 2014, we had a loss before taxes of $1.9 million and recognized an income tax benefit of $2.8 million resulting in an effective tax rate of 149.6%. The change in the tax rate resulted primarily from a projected increase in income subject to tax in the United States as compared to lower rate foreign jurisdictions.
25
Contractual Obligations
The following table reflects our contractual obligations as of April 5, 2015:
Payments Due by Period | ||||||||||||||||||||||||
Total | Less than 1 year |
1-3 years | 3-5 years | More than 5 years |
Other | |||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||
Purchase Obligations |
$ | 189,510 | $ | 180,844 | $ | 8,666 | $ | | $ | | $ | | ||||||||||||
Retirement Plan Contributions |
110,296 | 4,123 | 8,224 | 8,842 | 89,107 | | ||||||||||||||||||
Operating Lease Obligations |
49,856 | 12,329 | 16,083 | 9,219 | 12,225 | | ||||||||||||||||||
Other Long-Term Liabilities Reflected on the Balance Sheet under GAAP(1) |
55,603 | | 18,318 | | | 37,285 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 405,265 | $ | 197,296 | $ | 51,291 | $ | 18,061 | $ | 101,332 | $ | 37,285 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Included in Other Long-Term Liabilities are liabilities for customer advances, extended warranty, uncertain tax positions, deferred tax liabilities and other obligations. For certain long-term obligations, we are unable to provide a reasonably reliable estimate of the timing of future payments relating to these obligations and therefore we included these amounts in the column marked Other. |
Liquidity and Capital Resources
Our cash, cash equivalents and marketable securities balances decreased by $27.9 million in the three months ended April 5, 2015, to $1,271 million. Cash activity for the three months ended April 5, 2015 and March 30, 2014 was as follows:
For the Three Months Ended |
||||||||
April 5, 2015 |
March 30, 2014 |
|||||||
(in millions) | ||||||||
Cash provided by (used for) operating activities: |
||||||||
Net income, adjusted for non-cash items |
$ | 68.6 | $ | 77.9 | ||||
Change in operating assets and liabilities |
(31.1 | ) | (103.8 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used for) operating activities |
37.5 | (25.8 | ) | |||||
|
|
|
|
|||||
Net cash (used for) provided by investing activities |
(62.0 | ) | 97.6 | |||||
|
|
|
|
|||||
Net cash used for financing activities |
(50.8 | ) | (180.8 | ) | ||||
|
|
|
|
|||||
Decrease in cash and cash equivalents |
$ | (75.3 | ) | $ | (109.0 | ) | ||
|
|
|
|
In the three months ended April 5, 2015, changes in operating assets and liabilities used cash of $31.1 million. This was due to a $15.6 million increase in operating assets and a $15.5 million decrease in operating liabilities.
The increase in operating assets was due to a $24.7 million increase in accounts receivable due to higher sales, partially offset by a $6.0 million decrease in inventories and a $3.1 million decrease in prepayments and other assets. The decrease in operating liabilities was due to a $45.2 million decrease in accrued employee compensation due primarily to variable compensation and employee stock award payroll tax payments, and $1.0 million of retirement plan contributions, partially offset by a $13.9 million increase in other accrued liabilities, a $11.1 million increase in accounts payable due to higher sales, a $4.7 million increase in accrued income taxes and a $1.0 million increase in customer advance payments and deferred revenue.
Investing activities during the three months ended April 5, 2015 used cash of $62.0 million, due to $335.6 million used for purchases of marketable securities and $21.1 million used for purchases of property, plant and equipment, partially offset by proceeds from maturities and sales of marketable securities of $140.2 million and $148.6 million, respectively, proceeds from the sale of an equity investment of $4.8 million, and proceeds from life insurance of $1.1 million related to the cash surrender value from the cancellation of Teradyne owned life insurance policies. The decrease in purchases of property, plant and equipment of $10.1 million was primarily due to higher purchases of testers for customer leases in the three months ended March 30, 2014.
26
Financing activities during the three months ended April 5, 2015 used cash of $50.8 million, due to the repurchase of 2.4 million shares of common stock for $46.7 million at an average price of $19.40 per share, and $13.0 million used for dividend payments, partially offset by $8.9 million provided by the issuance of common stock under employee stock purchase and stock option plans.
In the three months ended March 30, 2014, changes in operating assets and liabilities used cash of $103.8 million. This was due to a $56.9 million increase in operating assets and a $46.9 million decrease in operating liabilities.
The increase in operating assets was due to a $58.9 million increase in accounts receivable due to higher sales and an increase in shipments later in the quarter and a $0.6 million increase in prepayments and other assets, partially offset by a $2.6 million decrease in inventories. The decrease in operating liabilities was due to a $48.0 million decrease in accrued employee compensation due primarily to variable compensation and employee stock award payroll tax payments, a $9.6 million decrease in accrued income taxes, a $4.3 million convertible debt interest payment, $1.4 million of retirement plan contributions, and a $0.9 million decrease in other accrued liabilities, partially offset by a $7.7 million increase in accounts payable due to higher sales and a $9.6 million increase in customer advance payments and deferred revenue.
Investing activities during the three months ended March 30, 2014 provided cash of $97.6 million, due to proceeds from maturities and sales of marketable securities that provided cash of $280.3 million and $101.4 million, respectively, and proceeds from life insurance of $4.4 million related to the cash surrender value from the cancellation of Teradyne owned life insurance policies on its retired chief executive officer, partially offset by $257.3 million used for purchases of marketable securities and $31.2 million used for purchases of property, plant and equipment.
Financing activities during the three months ended March 30, 2014 used cash of $180.8 million. $191.0 million of cash was used for payments on long-term debt related to convertible debt and the loan in Japan, partially offset by $10.2 million provided from the issuance of common stock under employee stock purchase and stock option plans.
In January 2015, our Board of Directors declared a quarterly dividend of $0.06 per share to be paid on March 24, 2015 to shareholders of record as of February 27, 2015. In the three months ended April 5, 2015, dividend payments were $13.0 million.
In January 2015, our Board of Directors authorized the repurchase of up to $500 million of common stock, $300 million of which we intend to repurchase in 2015. As of April 5, 2015 we repurchased 2.4 million shares of common stock for $46.7 million at an average price of $19.40.
While we declared a quarterly cash dividend and authorized a share repurchase program, we may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of Teradynes Board of Directors which will consider, among other things, Teradynes earnings, capital requirements and financial condition.
We believe our cash, cash equivalents and marketable securities balance will be sufficient to pay our quarterly dividend, execute our authorized share repurchase program and meet our working capital and expenditure needs for at least the next twelve months. The amount of cash, cash equivalents and marketable securities in the U.S. and our operations in the U.S. provide sufficient liquidity to fund our business activities in the U.S. We have approximately $650 million of cash outside the U.S. that if repatriated would incur additional taxes. Determination of the additional taxes that would be incurred is not practicable due to uncertainty regarding the remittance structure, the mix of earnings and earnings and profit pools in the year of remittance, and overall complexity of the calculation. Inflation has not had a significant long-term impact on earnings.
Equity Compensation Plans
As discussed in Note N: Stock Based Compensation in our 2014 Form 10-K, we have a 1996 Employee Stock Purchase Plan and a 2006 Equity and Cash Compensation Incentive Plan (the 2006 Equity Plan).
The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers, directors, consultants and/or advisors. Both plans were approved by our shareholders.
27
Recently Issued Accounting Pronouncements
In May 2014, the FASB issued Accounting Standard Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606, which will replace numerous requirements in U.S. GAAP, including industry-specific requirements, and provide companies with a single revenue recognition model for recognizing revenue from contracts with customers. The core principle of the new standard is that a company should recognize revenue to show the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to in exchange for those goods or services. On April 1, 2015, FASB proposed a deferral of the effective date of the new revenue standard by one year, until January 1, 2018. For us, the standard will be effective in the first quarter of 2018. Early adoption is permitted but not before the original effective date (that is, annual periods beginning after December 15, 2016). The two permitted transition methods under the new standard are the full retrospective method, in which case the standard would be applied to each prior reporting period presented, or the modified retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application. We have not yet selected a transition method. We are currently evaluating the impact of this ASU on our financial position and results of operations.
Item 3: | Quantitative and Qualitative Disclosures about Market Risk |
For Quantitative and Qualitative Disclosures about Market Risk affecting Teradyne, see Item 7a, Quantitative and Qualitative Disclosures about Market Risks, in our Annual Report on Form 10-K filed with the SEC on February 27, 2015. There were no material changes in our exposure to market risk from those set forth in our Annual Report for the fiscal year ended December 31, 2014.
Item 4: | Controls and Procedures |
As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.
28
Item 1: | Legal Proceedings |
We are subject to various legal proceedings and claims which have arisen in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our results of operations, financial condition or cash flows.
Item 1A: | Risk Factors |
In addition to other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A: Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2014, which could materially affect our business, financial condition or future results. The risk factors described in our Annual Report on Form 10-K remain applicable to our business.
The risks described in our Annual Report on Form 10-K are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
We may incur indebtedness.
On April 27, 2015, we entered into a five-year, senior secured revolving credit facility of $350.0 million. Subject to customary conditions, we may seek to obtain from existing or new lenders incremental commitments under the credit facility in an aggregate principal amount not to exceed $150.0 million. We have not borrowed any funds under this credit facility. We could borrow funds under this credit facility at any time for general corporate purposes and working capital. Incurring indebtedness, among other things, could:
| make it difficult to pay other obligations; |
| make it difficult to obtain any necessary future financing for working capital, capital expenditures, debt service requirements or other purposes; |
| require the dedication of a substantial portion of any cash flow from operations to service our indebtedness, thereby reducing the amount of cash flow available for other purposes, including capital expenditures; and |
| limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we compete. |
Our senior secured revolving credit facility contains customary restrictive covenants.
The agreement governing our senior secured revolving credit facility contains financial and other restrictive covenants that limit our ability to engage in certain activities, such as, subject to permitted exceptions, making capital expenditures in excess of certain thresholds, incurring additional secured indebtedness, and other customary restrictive covenants. Our failure to comply with financial and other restrictive covenants could result in immediate payment of any outstanding borrowings under the facility.
Item 2: | Unregistered Sales of Equity Securities and Use of Proceeds |
In January 2015, Teradynes Board of Directors cancelled the 2010 stock repurchase program and authorized a new stock repurchase program for up to $500 million of common stock, $300 million of which Teradyne intends to repurchase in 2015. The cumulative repurchases as of April 5, 2015, totaled 2.4 million shares of common stock for $46.7 million at an average price of $19.40.
29
The following table includes information with respect to repurchases we made of our common stock during the three months ended April 5, 2015 (in thousands except per share price):
Period |
(a) Total Number of Shares (or Units) Purchased |
(b) Average Price Paid per Share (or Unit) |
(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs |
(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that may Yet Be Purchased Under the Plans or Programs |
||||||||||||
January 1, 2015 February 1, 2015 |
496 | $ | 19.35 | | $ | 500,000 | ||||||||||
February 2, 2015 March 1, 2015 |
806 | $ | 19.41 | 802 | $ | 484,428 | ||||||||||
March 2, 2015 April 5, 2015 |
1,603 | $ | 19.40 | 1,602 | $ | 453,350 | ||||||||||
|
|
|
|
|
|
|||||||||||
2,905 | (1) | $ | 19.39 | (1) | 2,404 | |||||||||||
|
|
|
|
|
|
(1) | Includes 0.5 million shares at an average price of $19.35, withheld from employees for the payment of taxes. |
We satisfy U.S. federal and state minimum withholding tax obligations due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued, a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the minimum withholding amount due.
Item 4: | Mine Safety Disclosures |
Not Applicable
30
Item 6: | Exhibits |
Exhibit Number |
Description | |
31.1 | Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith) | |
31.2 | Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith) | |
32.1 | Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith) | |
32.2 | Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith) | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
31
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
TERADYNE, INC. |
Registrant |
/S/ GREGORY R. BEECHER |
Gregory R. Beecher |
Vice President, |
Chief Financial Officer and Treasurer |
(Duly Authorized Officer and Principal Financial Officer) |
May 8, 2015 |
32